NR3C1 and posterior cortical atrophy: Re-analysis of microarray data from PF179T-CAF-shGR-1 cells [7], as well as including primary CAFs from four PCa patients after GR activation and combined activation/pharmacological inhibition, revealed 132 specifically regulated (92 upregulated and 40 downregulated; Dex versus Ctrl) and 168 specifically regulated (63 upregulated and 105 downregulated; Dex versus Dex + RU486) GR-target genes after 24 h of GC treatment (Fig. 3A, B).